Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Site × ipatasertib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Prostatic Neoplasms 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 Carcinoma 2 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Oropharyngeal Neoplasms 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Glioblastoma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 5 pembrolizumab 4 durvalumab 4 Pemetrexed 4 palbociclib 3 Nivolumab 3 Fulvestrant 3 Carboplatin 3 Anastrozole 3 130-nm albumin-bound paclitaxel 3 selpercatinib 2 ribociclib 2 pralsetinib 2 cobimetinib 2 atezolizumab 2 abemaciclib 2 Vemurafenib 2 Radiosurgery 2 Paclitaxel 2 Letrozole 2 Gonadotropin-Releasing Hormone 2 Bevacizumab 2 Ascorbic Acid 2 AZD9833 2 trametinib 1 taletrectinib 1 spartalizumab 1 sotorasib 1 repotrectinib 1 relatlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡